Tandem Diabetes
Focus: Tandem Diabetes is a medical device company specializing in touchscreen insulin pumps for Type 1 and Type 2 diabetes management. They focus on closed-loop automated insulin delivery systems integrated with continuous glucose monitoring technology.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Tandem Diabetes
AI assessmentNot HiringNo open roles listed right now. Follow Tandem Diabetes to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
t:slim X2 with Control-IQ Technology
Growing
Growth
Flagship hybrid closed-loop insulin pump with touchscreen interface and predictive low glucose suspend—primary revenue driver and clinical evidence generator.
Control-IQ Technology
Help build intelligence for Tandem Diabetes
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.